Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
Status:
Terminated
Trial end date:
2021-04-13
Target enrollment:
Participant gender:
Summary
Condorde main objective is to evaluate the correlation between EGFR mutational status
determined after tumor biopsy and EGFR mutational status analyzed on ctDNA after liquid
biopsy. EGFR status will be assessed by real time PCR (rtPCR), digital PCR (dPCR) and Next
Generation Sequencing (NGS) in patients with chemotherapy naive lung carcinoma.